Roche received CE Mark approval for its Elecsys Interferon Gamma Release Assay (IGRA) TB blood test, enabling use for diagnosing tuberculosis infection (TBI) in routine laboratory settings. The approval is a positive regulatory milestone that could support future diagnostic adoption, though no financial figures or guidance changes were provided.
Roche received CE Mark approval for its Elecsys Interferon Gamma Release Assay (IGRA) TB blood test, enabling use for diagnosing tuberculosis infection (TBI) in routine laboratory settings. The approval is a positive regulatory milestone that could support future diagnostic adoption, though no financial figures or guidance changes were provided.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
